CJC-1295 with drug affinity complex. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: clinical.
Food, and carbohydrate in particular, raises insulin and blunts the growth-hormone pulse these compounds are meant to trigger. The two windows where you are naturally fasted and GH release is highest are early sleep and first thing on waking, which is why those are the only two sensible times.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–4 | 1 mg | once weekly | 0.4 mL | 40 u | 4 | 4 mg |
| Week 5 onward per 4 weeks from here on |
2 mg | once weekly | 0.8 mL | 80 u | 4 | 8 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Low reported | 1 mg | once weekly | 0.4 mL | 40 u | 5 doses |
| Standard | 2 mg | once weekly | 0.8 mL | 80 u | 2 doses |
| Trial dose | 30–60 mcg/kg | weekly | Set by body weight — can't be turned into a single amount to draw | ||
GHRH analogue conjugated to bind serum albumin, extending half-life from minutes to days. This produces sustained GH/IGF-1 elevation rather than pulses — a meaningfully different physiological profile from the no-DAC version.
Buy CJC-1295 DACPaid affiliate links.
Adding 2 mL of bacteriostatic water to a 5 mg vial gives 2.5 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for CJC-1295 DAC run from 1 mg to 2 mg, typically once weekly. This site lists each figure with the source it came from rather than giving a single recommended number.
At 2.5 mg/mL, a 1 mg dose is 40 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 5 doses.
CJC-1295 DAC is graded clinical. Human trial or approved-label dosing has been published for this compound. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
Compounds in the same class, or browse the full catalogue.
A tetra-substituted GHRH(1-29) analogue without the drug affinity complex, giving a short pulse rather than sustained elevation. F…
A growth hormone-releasing peptide with an approved diagnostic use in Japan for GH deficiency testing. Less receptor-selective tha…
Every compound compared in one table: dose range, how often, half-life and evidence tier.
Need this on one page to print, screenshot or send?
Make a dose card →